180469-63-0

Basic information

• Product Name: 5-iPF2α-VI
• Synonyms: 5-iPF2α-VI;5-iPF2α-VI Exclusive;(5-iPF2.alpha.-VI
• CAS NO: 180469-63-0
• Molecular Formula: C20H34O5
• Molecular Weight: 354.48096
• Mol File: 180469-63-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-iPF2α-VI(CAS DataBase Reference)
• NIST Chemistry Reference: 5-iPF2α-VI(180469-63-0)
• EPA Substance Registry System: 5-iPF2α-VI(180469-63-0)

Safety Data

• Hazardous Substances Data: 180469-63-0(Hazardous Substances Data)

Upstream product

• 180300-32-7 (E)-(S)-7-[(1S,2R,3R,5S)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-((Z)-oct-2-enyl)-cyclopentyl]-5-hydroxy-hept-6-enoic acid methyl ester 
• 249935-25-9 (E)-(S)-7-[(1S,2R,3R,5S)-3-Acetoxy-5-hydroxy-2-((Z)-oct-2-enyl)-cyclopentyl]-5-hydroxy-hept-6-enoic acid ethyl ester 
• 377078-58-5 C₃₅H₄₄O₇ 
• 213777-19-6 (1S,2R,3R,4R)-2-(tert-butyldiphenylsilyloxymethyl)-3-(formylmethyl)-1,4-bis-O-(triethylsilyl)cyclopentane-1,4-diol 
• 213777-18-5 (1S,2S,3R,4R)-1,4-Bis(triethylsilyloxy)-3-(methoxycarbonylmethyl)-2-tert-butyldiphenylsilyloxymethylcyclopentane 
• 377078-56-3 C₂₈H₃₂O₅ 
• 377078-55-2 C₂₈H₃₄O₅ 
• 377078-53-0 (1R,3S,4R,5R)-4-(tert-Butyl-diphenyl-silanyloxymethyl)-5-((Z)-oct-2-enyl)-cyclopentane-1,3-diol 
• 377078-57-4 C₃₅H₄₂O₇ 
• 377078-54-1 C₄₄H₅₂O₅Si 
• 377078-52-9 C₄₂H₇₂O₃Si₃ 
• 249935-23-7 (E)-7-[(1S,2R,3R,5S)-3-Acetoxy-5-hydroxy-2-((Z)-oct-2-enyl)-cyclopentyl]-5-oxo-hept-6-enoic acid ethyl ester 
• 4005-46-3 3-deoxy-1,2-O-isopropylidene-D-glucose 
• 155518-70-0 (R)-4-((3aR,5S,6aR)-2,2-Dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-[1,3]dioxolane-2-thione 

Relevant articles and documents

A cross-metathesis route to the 5-F2-isoprostanes

(Chemical Equation Presented) A library of eight 5-F2- isoprostanes was prepared through a ring-opening metathesis/cross-metathesis protocol between functionalized bicyclo[3.2.0]heptenes, ethylene, and α,β-unsaturated ketones. This sequence provided racemic enones in a regio- and stereoselective fashion that could be converted to enantiomerically enriched allylic alcohols through a catalyst-controlled asymmetric reduction. Completion of the sidechains, followed by global deprotection, resulted in a stereodivergent route to eight enantiomerically enriched 5-F2 isoprostanes. Overall, the synthesis of this library of known and anticipated lipid oxidation metabolites was achieved in 10 steps from commercially available 4-hydroxy-2-cyclopentenone.

Syntheses and preliminary pharmacological evaluation of the two epimers of the 5-F2t-isoprostane

The total synthesis of the 5-F2t-isoprostane 1 and its 5-epimer 2 from diacetone-D-glucose is described. We report preliminary data on the vascular properties of these compounds.

5-F2t-isoprostane, a human hormone?

Syntheses of the four enantiomerically pure diastereomers of 5-F2t-isoprostane (5-8) are described. The key step is the lipase-catalyzed chemo-enzymatic resolution of the racemic diol 40 to give the mono-acetates 41 and 42. The enantiomerically

Total synthesis of a novel isoprostane IPF(2α)-I and its identification in biological fluids

The first tokai synthesis of IPF(2α)-I 25 is described using D-glucose as starting material. This novel isoprostane has been used to establish its presence in human urine.